Journal
ENDOSCOPIC ULTRASOUND
Volume 8, Issue 4, Pages 235-240Publisher
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/eus.eus_16_19
Keywords
Contrast-enhanced endoscopic; endoscopic ultrasound; pancreatic cancer; prognosis; ultrasound
Categories
Funding
- Ministry of Research and Innovation, CNCS-UEFISCDI, within PNCDI III [PN-III-P4-ID-PCE-2016-0561]
- MRC [G0801588] Funding Source: UKRI
Ask authors/readers for more resources
Patients with unresectable pancreatic cancer have a poor prognosis. The analysis of prognostic factors before treatment may be helpful in determining the best therapeutic strategies. The aim of the PEACE study is to assess the vascularity of pancreatic malignant tumors using contrast-enhanced harmonic EUS (CEH-EUS) and to clarify the prognostic value of tumor vascularity in patients with locally advanced and metastatic pancreatic cancer. Hereby, we present the protocol of a prospective, nonrandomized, single-arm, multicenter study aiming to assess changes in tumor vascularity using CEH-EUS before and 2 months after treatment initiation in patients with unresectable, locally advanced/metastatic pancreatic cancer and to examine the correlation between vascular changes and treatment response, progression-free survival, and overall survival.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available